Advertisement

Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound

  • C. F. DietrichEmail author
  • B. Braden
  • M. Hocke
  • M. Ott
  • A. Ignee
Original Paper

Abstract

Background

Contrast enhanced ultrasound (CEUS) is a new imaging method for detection and characterisation of liver tumours. The role of CEUS in pancreatic disease is less obvious. We prospectively evaluated CEUS for characterization of undetermined solid pancreatic lesions (gold standard histology).

Patients and methods

A total of 112 solitary undetermined pancreatic masses (70 ductal adenocarcinoma and 42 neoplastic nodules of other origin) were prospectively examined in patients without metastatic disease using transabdominal ultrasound. Tumour enhancing features were analyzed in comparison to the surrounding pancreatic parenchyma in patients with adequate visualisation.

Results

The sign of iso-hypervascularity as a sign of non-ductal adenocarcinoma showed a sensitivity of 100%, specifity of 90% and accuracy of 93.8%. The sign of hypovascularity as a sign of ductal adenocarcinoma showed a sensitivity of 90%, specifity of 100% and an accuracy of 93.8%.

Conclusion

CEUS allows differential diagnosis of ductal adenocarcinoma and non-ductal adenocarcinoma (mainly neuroendocrine tumours and (microcystic) serous pancreatic adenoma) in the most of cases.

Keywords

Ultrasound Endoscopic ultrasound Differential diagnosis Pancreatic tumours 

References

  1. Adsay NV, Basturk O, Klimstra DS, Kloppel G (2004) Pancreatic pseudotumors: non-neoplastic solid lesions of the pancreas that clinically mimic pancreas cancer. Semin Diagn Pathol 21(4):260–267PubMedCrossRefGoogle Scholar
  2. D’Onofrio M, Caffarri S, Zamboni G, Falconi M, Mansueto G (2004) Contrast-enhanced ultrasonography in the characterization of pancreatic mucinous cystadenoma. J Ultrasound Med 23(8):1125–1129PubMedGoogle Scholar
  3. D’Onofrio M, Malago R, Vecchiato F, Zamboni G, Testoni M, Falconi M et al (2005a) Contrast-enhanced ultrasonography of small solid pseudopapillary tumors of the pancreas: enhancement pattern and pathologic correlation of 2 cases. J Ultrasound Med 24(6):849–854PubMedGoogle Scholar
  4. D’Onofrio M, Malago R, Zamboni G, Vasori S, Falconi M, Capelli P et al (2005b) Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology 5(4–5):398–402PubMedCrossRefGoogle Scholar
  5. D’Onofrio M, Zamboni G, Tognolini A, Malago R, Faccioli N, Frulloni L et al (2006) Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol 12(26):4181–4184PubMedGoogle Scholar
  6. Dietrich CF, Lee JH, Herrmann G, Teuber G, Roth WK, Caspary WF et al (1997) Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology 26(2):467–472PubMedCrossRefGoogle Scholar
  7. Dietrich CF, Leuschner MS, Zeuzem S, Herrmann G, Sarrazin C, Caspary WF et al (1999) Peri-hepatic lymphadenopathy in primary biliary cirrhosis reflects progression of the disease. Eur J Gastroenterol Hepatol 11(7):747–753PubMedCrossRefGoogle Scholar
  8. Dietrich CF, Chichakli M, Hirche TO, Bargon J, Leitzmann P, Wagner TO et al (2002) Sonographic findings of the hepatobiliary-pancreatic system in adult patients with cystic fibrosis. J Ultrasound Med 21(4):409–416PubMedGoogle Scholar
  9. Dietrich CF, Ignee A, Trojan J, Fellbaum C, Schuessler G (2004) Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 53(3):401–405PubMedCrossRefGoogle Scholar
  10. Dietrich CF, Kratzer W, Strobe D, Danse E, Fessl R, Bunk A et al (2006) Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 12(11):1699–1705PubMedGoogle Scholar
  11. Goldstein HM, Neiman HL, Bookstein JJ (1974) Angiographic evaluation of pancreatic disease. A further appraisal. Radiology 112(2):275–282PubMedGoogle Scholar
  12. Hirooka Y, Goto H, Ito A, Hayakawa S, Watanabe Y, Ishiguro Y et al (1998) Contrast-enhanced endoscopic ultrasonography in pancreatic diseases: a preliminary study. Am J Gastroenterol 93(4):632–635PubMedCrossRefGoogle Scholar
  13. Hocke M, Schulze E, Gottschalk P, Topalidis T, Dietrich CF (2006) Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 12(2):246–250PubMedGoogle Scholar
  14. Itoh T, Hirooka Y, Itoh A, Hashimoto S, Kawashima H, Hara K et al (2005) Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 100(1):144–152PubMedCrossRefGoogle Scholar
  15. Johnson PT, Outwater EK (1999) Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Radiology 212(1):213–218PubMedGoogle Scholar
  16. Kitano M (2005) Clinical significance of vascular assessment by contrast-enhanced harmonic ultrasonography of pancreatic carcinomas. J Gastroenterol 40(6):666–668PubMedCrossRefGoogle Scholar
  17. Kitano M, Kudo M, Maekawa K, Suetomi Y, Sakamoto H, Fukuta N et al (2004) Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 53(6):854–859PubMedCrossRefGoogle Scholar
  18. Kobayashi A, Yamaguchi T, Ishihara T, Tadenuma H, Nakamura K, Saisho H (2005) Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy. Gut 54(7):1047PubMedCrossRefGoogle Scholar
  19. Koito K, Namieno T, Nagakawa T, Morita K (1997) Inflammatory pancreatic masses: differentiation from ductal carcinomas with contrast-enhanced sonography using carbon dioxide microbubbles. AJR Am J Roentgenol 169(5):1263–1267PubMedGoogle Scholar
  20. Koito K, Namieno T, Nagakawa T, Hirokawa N, Ichimura T, Syonai T et al (2001) Pancreas: imaging diagnosis with color/power Doppler ultrasonography, endoscopic ultrasonography, and intraductal ultrasonography. Eur J Radiol 38(2):94–104PubMedCrossRefGoogle Scholar
  21. Masaki T, Ohkawa S, Amano A, Ueno M, Miyakawa K, Tarao K (2005) Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer 103(5):1026–1035PubMedCrossRefGoogle Scholar
  22. Miyata T, Tomiyama T, Tano S, Ueno N (1998) Differential diagnosis of pancreatic tumor by contrast enhanced color Doppler ultrasonography. Nippon Rinsho 56(4):1024–1029PubMedGoogle Scholar
  23. Nagase M, Furuse J, Ishii H, Yoshino M (2003) Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med 22(8):789–795PubMedGoogle Scholar
  24. Numata K, Ozawa Y, Kobayashi N, Kubota T, Shimada H, Nozawa A et al (2005) Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings. J Gastroenterol 40(6):631–640PubMedCrossRefGoogle Scholar
  25. Ohshima T, Yamaguchi T, Ishihara T, Yoshikawa M, Kobayashi A, Sakaue N et al (2004) Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wide-band Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor. Pancreas 28(3):335–343PubMedCrossRefGoogle Scholar
  26. Oldenburg A, Hohmann J, Foert E, Skrok J, Hoffmann CW, Frericks B et al (2005) Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med 26(4):277–284PubMedCrossRefGoogle Scholar
  27. Oshikawa O, Tanaka S, Ioka T, Nakaizumi A, Hamada Y, Mitani T (2002) Dynamic sonography of pancreatic tumors: comparison with dynamic CT. AJR Am J Roentgenol 178(5):1133–1137PubMedGoogle Scholar
  28. Rickes S, Unkrodt K, Ocran K, Neye H, Wermke W (2003) Differentiation of neuroendocrine tumors from other pancreatic lesions by echo-enhanced power Doppler sonography and somatostatin receptor scintigraphy. Pancreas 26(1):76–81PubMedCrossRefGoogle Scholar
  29. Rickes S, Randhan W, Malfertheiner P (2004) Differentiation of cystic pancreatic lesions by echo-enhanced sonography with pulse inversion imaging—presentation of case reports. Z Gastroenterol 42(4):317–321PubMedCrossRefGoogle Scholar
  30. Rickes S, Monkemuller K, Malfertheiner P (2006) Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors. JOP 7(6):584–592PubMedGoogle Scholar
  31. Schima W (2006) MRI of the pancreas: tumours and tumour-simulating processes. Cancer Imaging 6:199–203PubMedCrossRefGoogle Scholar
  32. Schueller G, Schima W, Schueller-Weidekamm C, Weber M, Stift A, Gnant M et al (2006) Multidetector CT of pancreas: effects of contrast material flow rate and individualized scan delay on enhancement of pancreas and tumor contrast. Radiology 241(2):441–448PubMedCrossRefGoogle Scholar
  33. Sofuni A, Iijima H, Moriyasu F, Nakayama D, Shimizu M, Nakamura K et al (2005) Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 40(5):518–525PubMedCrossRefGoogle Scholar
  34. von Herbay A, Vogt C, Haussinger D (2002) Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol 179(5):1273–1279Google Scholar
  35. von Herbay A, Vogt C, Willers R, Haussinger D (2004) Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 23(12):1557–1568Google Scholar
  36. Yang EY, Joehl RJ, Talamonti MS (1994) Cystic neoplasms of the pancreas. J Am Coll Surg 179(6):747–757PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • C. F. Dietrich
    • 1
    Email author
  • B. Braden
    • 2
    • 3
  • M. Hocke
    • 5
  • M. Ott
    • 4
  • A. Ignee
    • 1
  1. 1.Medical and Imaging DepartmentCaritas-KrankenhausBad MergentheimGermany
  2. 2.Medical Department IUniversity Hospital FrankfurtFrankfurt am MainGermany
  3. 3.Medical DepartmentJohn Radcliffe HospitalOxfordUK
  4. 4.Department of PathologyCaritas-KrankenhausBad MergentheimGermany
  5. 5.Department of Internal Medicine IIFriedrich Schiller University JenaJenaGermany

Personalised recommendations